Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Powis

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Molecular Cancer Research : MCR|January 26, 2012
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cellsElena V Sheveleva, Terry H Landowski, Betty K Samulitis, et al.
Bioorganic & Medicinal Chemistry|September 8, 2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domainLei Du-Cuny, Zuohe Song, Sylvestor Moses, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survivalJennifer Raffel, Achyut K Bhattacharyya, Alfred Gallegos, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Recent development of anticancer therapeutics targeting AktJohn K Morrow, Lei Du-Cuny, Lu Chen, et al.
The Journal of Biological Chemistry|June 21, 2003
Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motifWalter H Watson, Jan Pohl, William R Montfort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imagingBénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Carcinogenesis|May 29, 2004
Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouseDebbie Mustacich, Amary Wagner, Ryan Williams, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478Bénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Molecular Cancer Therapeutics|January 14, 2009
Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activityNathan T Ihle, Robert Lemos, David Schwartz, et al.
Experimental Dermatology|June 16, 2010
IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytesNancy J Poindexter, Ryan R Williams, Garth Powis, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Molecular Cancer Research : MCR|January 26, 2012
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cellsElena V Sheveleva, Terry H Landowski, Betty K Samulitis, et al.
Bioorganic & Medicinal Chemistry|September 8, 2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domainLei Du-Cuny, Zuohe Song, Sylvestor Moses, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survivalJennifer Raffel, Achyut K Bhattacharyya, Alfred Gallegos, et al.
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Recent development of anticancer therapeutics targeting AktJohn K Morrow, Lei Du-Cuny, Lu Chen, et al.
The Journal of Biological Chemistry|June 21, 2003
Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motifWalter H Watson, Jan Pohl, William R Montfort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imagingBénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Carcinogenesis|May 29, 2004
Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouseDebbie Mustacich, Amary Wagner, Ryan Williams, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478Bénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Molecular Cancer Therapeutics|January 14, 2009
Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activityNathan T Ihle, Robert Lemos, David Schwartz, et al.
Experimental Dermatology|June 16, 2010
IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytesNancy J Poindexter, Ryan R Williams, Garth Powis, et al.
Pageof 10